2022 Health Utilisation Study (HUS) Round 2 - cross-country report on findings from the Primary Child Caregiver cohort sample SAGE background document Malaria Download: EN
2022 ∙ SAGE Modelled public health impact and cost effectiveness estimates of RTS,S/AS01 malaria vaccine in perennial and seasonal settings (August 2021) SAGE background document Malaria Download: EN
2022 ∙ SAGE Statistical report on the results of the RTS,S/AS01 Malaria Vaccine Pilot Evaluation 24 months after the vaccine was introduced (September 2021, v1.2) SAGE background document Malaria Download: EN
2022 ∙ SAGE Full Evidence Report on the RTS,S/AS01 Malaria Vaccine SAGE background document Malaria Download: EN
2022 ∙ SAGE GRADE and Evidence to Recommendation tables on RTS,S/AS01 malaria vaccine Evidence to recommendation table Malaria Download: EN
2021 ∙ Daniel Chandramohan, Brian Greenwood Seasonal Malaria Vaccination with or without Seasonal Malaria Chemoprevention Malaria Download: EN
2019 ∙ Halidou Tinto, Walter Otieno, Samwel Gesase, Hermann Sorgho, Lucas Otieno Long-term incidence of severe malaria following RTS,S/AS01 vaccination in children and infants in Africa: an open-label 3-year extension study of a phase 3 randomised controlled trial Malaria Download: EN
2015 ∙ RTS,S Clinical Trials Partnership Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial Malaria Download: EN
